Stock Market News1 month EMA Panel Endorses Lilly’s Omvoh for Expanded Use in Crohn’s Disease Zacks
The CHMP’s opinion is based on late-stage data, which show that LLY’s Omvoh is effective in Crohn’s disease patients with or without prior biologic failure.
XThe CHMP’s opinion is based on late-stage data, which show that LLY’s Omvoh is effective in Crohn’s disease patients with or without prior biologic failure.
X